Zen Brief

California's proposed billionaire tax is the main economic story, alongside a Meta tax agreement that revives the enforcement debate. In health, FDA review paths for Alzheimer's drugs and cancer vaccines are in focus, and an Alaska lawsuit raises questions about DOJ election oversight.

1. 1 California considers landmark billionaire wealth taxEconomists warn California's proposed billionaire tax could speed the exit of wealthy residents to lower-tax states as voters weigh the measure.
2. 2 DOJ challenges Alaska ballot design in federal lawsuitA federal suit over two Alaska candidates' similar names raises questions about DOJ authority over state election certification.
3. 3 Meta's California tax deal exposes wealth tax weaknessMeta's agreement with California eases Zuckerberg's tax burden and revives debate over enforcing the state's unresolved billionaire wealth tax.
4. 4 Repurposed drugs test could reshape Alzheimer's FDA approval pathA federally funded trial tests existing diabetes and ADHD drugs on Alzheimer's patients, which may give drugmakers a faster, cheaper FDA route.
5. 5 Cancer Vaccine Trial Results Spark Biotech Stock RallyEarly results showing reduced cancer recurrence renew Wall Street interest in personalized vaccine makers and test FDA review timelines.